Form 4: Novavax Executive James Patrick Kelly Reports Stock Transactions

EVP, CFO, and Treasurer of Novavax, James Patrick Kelly, reports the acquisition and disposal of common stock and restricted stock units on August 16, 2024.

Summary

• On August 16, 2024, James Patrick Kelly, the EVP, CFO, and Treasurer of Novavax Inc., engaged in transactions involving the company's stock.
• Kelly acquired 2,367 shares of common stock through the exercise of restricted stock units (RSUs) at a price of $12.96 per share.
• Simultaneously, Kelly disposed of 1,223 shares of common stock to cover tax obligations at a price of $12.96 per share.
• Following these transactions, Kelly directly owns 14,429 shares of Novavax common stock.
• The reported transactions relate to restricted stock units that vest in three equal installments on the anniversaries of the grant date, contingent upon continued employment.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by an executive, with no inherent positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common practice for publicly traded companies. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine stock activity by an executive.

Key Dates